ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Jenying Deng
Matched on ORCID iD 0009-0009-8956-9634; OpenAlex author ID A5012982167. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2021: 3 papers · 2022: 1 paper
Papers 4
- 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. First author DOI 10.1172/jci151604↗
- Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Co-author DOI 10.1038/s41419-021-03970-8↗
- Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. Co-author DOI 10.1158/2159-8290.cd-20-1228↗
- DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. Co-author DOI 10.1172/jci.insight.146133↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xinqun Li · 4 shared papers, 2021–2022 · strength 0.45
- Paper Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. DOI 10.1038/s41419-021-03970-8↗
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Ya’an Kang · 4 shared papers, 2021–2022 · strength 0.45
- Paper Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. DOI 10.1038/s41419-021-03970-8↗
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Jason B. Fleming · 4 shared papers, 2021–2022 · strength 0.45
- Paper Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. DOI 10.1038/s41419-021-03970-8↗
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Michael P. Kim · 4 shared papers, 2021–2022 · strength 0.45
- Paper Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. DOI 10.1038/s41419-021-03970-8↗
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Bingbing Dai · 3 shared papers, 2021 · strength 0.34
- Paper Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. DOI 10.1038/s41419-021-03970-8↗
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. DOI 10.1158/2159-8290.cd-20-1228↗
- Eugene Jon Koay · 3 shared papers, 2021–2022 · strength 0.33
- Paper DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. DOI 10.1172/jci.insight.146133↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. DOI 10.1158/2159-8290.cd-20-1228↗
- Matthew H. G. Katz · 2 shared papers, 2021–2022 · strength 0.23
- Anirban Maitra · 2 shared papers, 2021–2022 · strength 0.21
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. DOI 10.1158/2159-8290.cd-20-1228↗
- Florencia M. McAllister · 2 shared papers, 2021–2022 · strength 0.21
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. DOI 10.1158/2159-8290.cd-20-1228↗
- David Roife · 1 shared paper, 2021 · strength 0.12
- Huocong Huang · 1 shared paper, 2021 · strength 0.12
- Rolf A. Brekken · 1 shared paper, 2021 · strength 0.12
- Jeffrey H. Lee · 1 shared paper, 2022 · strength 0.11
- Jianhua Ling · 1 shared paper, 2022 · strength 0.11
- Huamin Wang · 1 shared paper, 2022 · strength 0.11
- Robert A. Wolff · 1 shared paper, 2022 · strength 0.11
- Naruhiko Ikoma · 1 shared paper, 2022 · strength 0.11
- Ronald Anthony Depinho · 1 shared paper, 2022 · strength 0.11
- Paul J. Chiao · 1 shared paper, 2022 · strength 0.11
- Manoop S. Bhutani · 1 shared paper, 2022 · strength 0.11
- Jeffrey E. Lee · 1 shared paper, 2022 · strength 0.11
- Brian R. Weston · 1 shared paper, 2022 · strength 0.11
- Shubham Pant · 1 shared paper, 2022 · strength 0.11
- Ching-Wei David Tzeng · 1 shared paper, 2022 · strength 0.11
- Timothy Paul Heffernan · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.